Advertisement
Screener

Nuo Therapeutics, Inc. (AURX) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings

2.9 / 5 stars · 32/56 Roast Me

Nuo Therapeutics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings

Nuo Therapeutics, Inc. (AURX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$201.06 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-15.

Discontinued › Income Statement › Other Income

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2014-05-15

  • Nuo Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2014-03-31 was -$201.06K.
  • Nuo Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2013-12-31 was $0.00.
  • Nuo Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2013-09-30 was $0.00.
  • Nuo Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2013-06-30 was $0.00.
  • Nuo Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2013 was $0.00.
  • Nuo Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2012 was -$4.33M.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month
2014-03-31-$201.06K
10-Q · filed 2014-05-15
-$201.06K
derived: sum of 2 quarters · filed 2014-05-15
-$201.06K
derived: sum of 3 quarters · filed 2014-05-15
-$201.06K
derived: sum of 4 quarters · filed 2014-05-15
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
$0.00
derived: sum of 2 quarters · filed 2014-03-31
$0.00
derived: sum of 3 quarters · filed 2014-03-31
$0.00
10-K · filed 2014-03-31
2013-09-30$0.00
10-Q · filed 2013-11-12
$0.00
derived: sum of 2 quarters · filed 2013-11-12
$0.00
10-Q · filed 2013-11-12
$0.00
derived: sum of 4 quarters · filed 2014-03-31
2013-06-30$0.00
10-Q · filed 2013-08-08
$0.00
10-Q · filed 2013-08-08
$0.00
derived: sum of 3 quarters · filed 2014-03-31
$0.00
derived: sum of 4 quarters · filed 2014-03-31
2013-03-31$0.00
derived: 10-K 12 month − 3 quarters · filed 2014-03-31
$0.00
derived: sum of 2 quarters · filed 2014-03-31
$0.00
derived: sum of 3 quarters · filed 2014-03-31
-$4.33M
derived: sum of 4 quarters · filed 2014-03-31
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
$0.00
derived: sum of 2 quarters · filed 2014-03-31
-$4.33M
derived: sum of 3 quarters · filed 2014-03-31
-$4.33M
10-K · filed 2014-03-31
2012-09-30$0.00
10-Q · filed 2013-11-12
-$4.33M
derived: sum of 2 quarters · filed 2013-11-12
-$4.33M
10-Q · filed 2013-11-12
2012-06-30-$4.33M
10-Q · filed 2013-08-08
-$4.33M
10-Q · filed 2013-08-08